Press Release – December 2, 2008

Cellulogix International Inc. www.cellulogixintl.com launches coalescing enterprise as Regenerative Therapies gains momentum.

Cellulogix International Inc. Montreal, Canada, formally advances its interests in the global Stem Cell Therapy commercial industry. Known for its advanced applications in human cord blood and in fruitful collaboration with some of the most reliable and reputable biotech companies in Canada, Europe, Russia, South Africa, South America, and the United States to establish protocols to recondition cells that are used in treatments. With Regenerative Therapies gaining momentum due to the advancement of emerging needs and interests on every continent, Cellulogix International Inc. www.cellulogixintl.com is positioned as the leading commercial provider of therapeutic applications of human cord blood. Research is showing the International demand for a universal product with unlimited and undifferintiated cells, condition specific protocols tailored to each patient, to maximize the targeting of cells to areas of need. With industry trends showing progress in this area, Cellulogix International Inc. www.cellulogixintl.com is now an established leader and also announces the launch of the new Adult Stem Cell treatment procedure referred to as “Apheresis” methodology which is known for its anti-aging qualities. A universal product from and for the patient donor.

For more information and a consultation with a Scientist, please phone 514-448-2199

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix: I’m Phil D. and I had my transplant the week of May 5th 2009. We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.